AstraZeneca PLC
AZNNext catalyst
Durvalumab
Triple Negative Breast Cancer
Get an email about AZN's next catalysts
Track AstraZeneca (AZN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 81 more upcoming events in our data (Phase 2 readout, Phase 3 readout).See the timeline
83 upcoming, 9 past
Durvalumab Phase 2 Est. Readout
Estimated primary completion for Durvalumab trial (NCT03158064) in Germ Cell Tumor. Topline data typically follows completion by weeks to months.
SourceAZD0901 Phase 2 Est. Readout
Primary completion for AZD0901 trial (NCT07069712) in Gastroesophageal Adenocarcinoma
SourceAZD0754 Phase 2 Est. Readout (APOLLO)
Primary completion for AZD0754 trial (NCT06267729) in Metastatic Prostate Cancer
improved cardiac function in some, though not all, patients
SourceTremelimumab Phase 2 Est. Readout
Estimated primary completion for Tremelimumab trial (NCT05000710) in Metastatic or Locally Advanced NSCLC. Topline data typically follows completion by weeks to months.
SourceAcalabrutinib Phase 2 Est. Readout
Estimated primary completion for Acalabrutinib trial (NCT05065554) in IgM MGUS. Topline data typically follows completion by weeks to months.
Sourceeculizumab Phase 3 Est. Readout (ECU-NMO-304)
Primary completion for eculizumab trial (NCT06724809) in NMOSD
SourceBaxdrostat/dapagliflozin Phase 2 Est. Readout
Primary completion for Baxdrostat/dapagliflozin trial (NCT07222917) in Chronic Kidney Disease and Hypertension
SourceDurvalumab Phase 3 Est. Readout (CompARE)
Estimated primary completion for Durvalumab trial (NCT04116047) in Oropharyngeal Cancer. Topline data typically follows completion by weeks to months.
SourceHow AZN's past catalysts played out
Market Overview
Stock performance and key metrics
AstraZeneca plc (/ˌæstrəˈzɛnəkə/) (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
WebsiteMEDI8897
Respiratory Syncytial Virus Infections
AZD1152
Acute Myeloid Leukemia
Dapagliflozin propanediol (FORXIGA™/FARXIGA™1)
AMI
cyclophosphamide, bortezomib, and dexamethasone (CyBorD) regimen
AL Amyloidosis
NOLVADEX (tamoxifen)
Breast Cancer
AZD9291
Advanced Non Small Cell Lung Cancer
Baxdrostat/dapagliflozin
Chronic Kidney Disease and Hypertension
Saruparib
Prostate Cancer
Sulphonylurea
Type 2 Diabetes
Datopotamab Deruxtecan
Non-small Cell Lung Cancer
Budesonide/formoterol pMDI + spacer
Asthma
Saxagliptin, Onglyza
Type 2 Diabetes Mellitus
Theophylline
Asthma
Anastrazole (Arimidex)
Breast Cancer
Aclidinium bromide/formoterol Fixed-Dose Combination (FDC)
Chronic Obstructive Pulmonary Disease
Gemcitabine + cisplatin + S-1
Biliary Tract Cancer
Taxane
Breast Cancer; HER2-positive; Metastatic
Acetylsalicylic acid ASA
Acute Coronary Syndrome
Abiraterone Oral Tablet
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Olanzapine, risperidone
Schizophrenia
Oleclumab
Non-Small Cell Lung Cancer
Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Sodium Zirconium Cyclosilicate (ZS)
Hyperkalemia
Gefitinib
Non-Small Cell Lung Cancer
Gemcitabine + S-1
Biliary Tract Cancer
Tremelimumab
Advanced Hepatocellular Carcinoma
Aclidinium Bromide/Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Pramlintide acetate
Diabetes Mellitus, Type 1
Tozorakimab
Chronic Obstructive Pulmonary Disease (COPD)
Medi-546
Systemic Lupus Erythematosus
AZD9291 Dosing
Lung Cancer
Gemcitabine + cisplatin + albumin-bound paclitaxel
Biliary Tract Cancer
Tozorakimab Dose Regimen 2
Chronic Obstructive Pulmonary Disease
Raloxifene
Breast Cancer
Ramucirumab+ paclitaxel
Gastric Cancer
Ciclesonide nasal spray
Hay Fever
Ropivacaine
Anesthesia,Spinal
AZD4831
Heart Failure With Preserved Ejection Fraction
Seasonal influenza virus vaccine
Asthma
ARIMIDEX (anastrazole)
Breast Cancer
candsartan cilexetil
Hypertension
Gemcitabine/Cisplatin
Biliary Tract Cancer
Nexium
Erosive Esophagitis
Eplontersen
Transthyretin Amyloid Cardiomyopathy
omefas
Severe Hypertriglyceridemia
ZNS
Migraine
pexelizumab
Cardio-pulmonary Bypass
Benralizumab (Medi-563)
Asthma
SEROQUEL (quetiapine fumarate) Tablets
Bipolar Disorder
Lithium carbonate
Acute Bipolar Depression
Metformin XR
Type 2 Diabetes
Dato-DXd
Breast Cancer
SSRI/Clomipramine
Obsessive Compulsive Disorder
MEDI4736 + Tremelimumab
Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN
Escitalopram oxylate
Generalized Anxiety Disorder
Mepolizumab
Eosinophilic Granulomatous Vasculitis
Laroprovstat
Hypercholesterolaemia
HFA MDI
Asthma
Pulmicort (budesonide) Respules
Asthma
Symbicort
COPD Patients
Benralizumab
Asthma
exenatide
Type 2 Diabetes Mellitus
Durvalumab +Tremelimumab
Non Small Cell Lung Carcinoma NSCLC
Aclidinium bromide
Chronic Obstructive Pulmonary Disease (COPD)
Saxagliptin, + insulin
Type 2 Diabetes
Exenatide (AC2993)
Diabetes Mellitus, Type 2
Benralizumab + Mometasone Furoate
Nasal Polyposis
HFO-1234ze(E)
Mucociliary Clearance
Osimertinib
Lung Cancer
Tiotropium
Chronic Obstructive Pulmonary Disease (COPD)
Terbutaline sulphate
Asthma
ALXN2060
Symptomatic Transthyretin Amyloid Cardiomyopathy
Selumetinib
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
Metformin (blinded)
Type 2 Diabetes
Ciclesonide
Perennial Allergic Rhinitis
Baxdrostat
Resistant Hypertension
Aclidinium bromide/Formoterol Fumarate (AB/FF)
Chronic Obstructive Pulmonary Disease
TC-5214
Major Depressive Disorder
Tezepelumab
Moderate to Severe Asthma
AZD9833
ER-Positive HER2-Negative Breast Cancer
Benralizumab Arm A
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
formoterol
Asthma
amoxicillin clavulanate
Infections
Saxagliptin
Type 2 Diabetes
Gefitinib (Iressa)
Cancer
MEDI4736
Squamous Cell Carcinoma of the Head and Neck
Candesartan cilexetil
Hypertension
Citalopram
Major Depressive Disorder
Tamoxifen (Nolvadex)
Breast Cancer
BCG
Non-Muscle- Invasive Bladder Cancer
Durvalumab (MEDI4736)
Non-muscle-invasive Bladder Cancer
exenatide, long acting release
Type 2 Diabetes Mellitus
MEDI4736 (Durvalumab) + Tremelimumab
Advanced Solid Malignancies
Rosuvastatin (Crestor)
Hypercholesterolemia
BGF MDI
Asthma
Tezepelumab (APFS)
Asthma
BGF MDI HFO
Chronic Obstructive Pulmonary Disease (COPD)
Datopotamab deruxtecan (Dato-DXd)
Non-small Cell Lung Cancer (NSCLC)
exenatide once weekly
Type 2 Diabetes Mellitus
Gefitinib, raltitrexed
Colorectal Cancer
Zibotentan/Dapagliflozin
Chronic Kidney Disease With High Proteinuria
ABT-335 plus rosuvastatin
Dyslipidemia
Acetylsalicylic acid (ASA)
Acute Ischaemic Stroke
Quetiapine Fumarate (Seroquel™) drug, mood stabilizer (mood)
Bipolar Disorder
ATACAND
Hypertension
AC2993
Diabetes Mellitus, Type 2
Symbicort Turbuhaler
Bronchial Asthma
rosiglitazone
Diabetes Mellitus, Type 2
Durvalumab plus chemotherapy
Small Cell Lung Carcinoma Extensive Disease
AZD5156 (Parent study Sentinel Safety Cohort)
COVID-19, SARS-CoV-2
Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level
Hyperkalaemia
5-fluorouracil
Colorectal Cancer
Saxagliptin + Metformin
Diabetes Mellitus, Type 2
Budesonide/formoterol (SYMBICORT) pMDI
Asthma
Nirsevimab
Respiratory Syncytial Virus Infections
Symbicort, used twice daily (b.i.d) and as needed (prn)
Asthma
Ranitidine
Gastric Ulcer
D9421-C
Crohn's Disease
Balcinrenone/dapagliflozin
Renal Insufficiency, Chronic
Pulmicort Turbuhaler
Asthma
Camizestrant
Advanced Breast Cancer
Cimetidine
Stress Ulcer Prophylaxis
Gemcitabine monotherapy
Biliary Tract Cancer
Puxitatug Samrotecan
Endometrial Cancer
FLOT chemotherapy
Gastrointestinal Neoplasms
5-fluorouracil (in FOLFOX)
Colorectal Cancer
Rilvegostomig
Hepatocellular Carcinoma
Daptomycin
Skin Diseases
Epanova
Hypertriglyceridemia
MEDI4736 (durvalumab)
Non - Small Cell Lung Cancer NSCLC
Intralipid
Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy
exenatide twice daily (BID)
Type 2 Diabetes Mellitus
Thiazolidinedione (Pioglitazone)
Type 2 Diabetes
Roxadustat
Anemia
Cisplatin + Gemcitabine
Unresectable Locally Advanced Urothelial Cancer
ABT-143
Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
ZD4054
Prostate Cancer
Capivasertib
Triple Negative Breast Neoplasms
corn oil control
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Conventional Asthma Therapy
Asthma
Pemetrexed/Carboplatin
Non-Small Cell Lung Cancer
pravastatin
Hyperlipoproteinemia Type III
candesartan cilexetil (Atacand)
Hypertension
AZD1222
COVID-19
Durvalumab + SoC chemotherapy
Carcinoma, Non-Small-Cell Lung
ZD1839 (Gefitinib)
Carcinoma
faslodex
Hormone Receptor Positive Breast Cancer
Amitriptyline
Major Depressive Disorder
Single agent chemotherapy
Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Carboplatin+Paclitaxel
Advanced Ovarian Cancer
NKTR-118
Opioid-Induced Constipation (OIC)
Zirconium Cyclosilicate
Hyperkalemia
Cediranib
Metastatic Colorectal Cancer
Olaparib tablets
Epithelial Ovarian Cancer
propranolol
Migraine Without Aura
Quetiapine SR
Anxiety Disorders
Metformin IR
Type 2 Diabetes
Domvanalimab
Non-Small Cell Lung Cancer
Adjuvant durvalumab
Non Small Cell Lung Cancer
Lomustine Chemotherapy
Recurrent Glioblastoma
AZD2816
COVID-19
Rosuvastatin Dose 1
Dyslipidaemia
Roflumilast
Chronic Obstructive Pulmonary Disease (COPD)
Symbicort pMDI
Asthma
Acalabrutinib
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Seroquel SR
Schizophrenia
Anifrolumab
Lupus Nephritis
Savolitinib
Carcinoma
Exantide with Dapagliflozin
Diabetes Mellitus
Epoetin alfa
Anemia
Sodium Zirconium Cyclosilicate
Hyperkalemia
AZD5335
Epithelial Ovarian Cancer
divalproex
Bipolar I Disorder
Laroprovstat/Rosuvastatin 2
Hypercholesterolaemia
FG-4592
Anemia
Esomeprazole (D961H) twice daily
Refractory Reflux Esophagitis
Chlorambucil
Untreated Chronic Lymphocytic Leukemia
Terbutaline Turbuhaler
Asthma
Rosuvastatin calcium
Hypercholesteremia
Tarlatamab
Small-cell Lung Cancer
Esomeprazole magnesium (Nexium)
Zollinger-Ellison Syndrome
tralokinumab
Ulcerative Colitis
Glyburide
Diabetes
Seloken ZOK/Toprol-XL
Heart Failure, Congestive
Lenbelintide
Obesity or Overweight
Quetiapine Fumarate Extended- Release
Schizophrenia
BDA MDI HFO
Asthma
Zolmitriptan
Migraine
biphasic insulin aspart
Diabetes Mellitus, Type 2
Anastrozole (Arimidex)
Breast Cancer
MEDI3250
Healthy Japanese Children Age 7 Years Through 18 Years
AZD0780
Heterozygous Familial Hypercholesterolaemia
exenatide/insulin glargine
Type 2 Diabetes Mellitus
Candesartan
Congestive Heart Failure
metoprolol succinate
Hypertension
carboplatin
Ovarian Cancer
Quetiapine XR
Bipolar Disorder
lithium
Bipolar I Disorder
Budesonide/formoterol pMDI
Asthma
Tamoxifen alone
Early-stage Breast Cancer
Exenatide once weekly suspension
Diabetes Mellitus, Type 2
Esomeprazole IV
Gastrointestinal Hemorrhage
Ethyl-eicosapentaenoic acid (EPA)
Schizophrenia
Dapagliflozin 10 milligram (mg)
COVID-19
Quetiapine Fumarate Sustained Release
Major Depressive Disorder
DS-8201a
Colorectal Neoplasm
Misoprostol
Postpartum Hemorrhage
budesonide (Pulmicort)
Chronic Obstructive Pulmonary Disease
MEDI4736 (Durvalumab)+Tremelimumab
Non-Small-Cell Lung Carcinoma NSCLC
budesonide and budesonide/formoterol
Asthma
Ipratropium bromide
Asthma
fluticasone/salmeterol
Asthma
Chemoimmunotherapy
Chronic Lymphocytic Leukemia
Androgen blockade + radiation therapy
Prostate Cancer
Ticagrelor mashed pills
Acute Coronary Syndrome
Fulvestrant
Breast Neoplasm Female
quetiapine fumarate or valproate
Bipolar Disorder
Administration of quetiapine XR
Schizophrenia
AZD0585
Hypertriglyceridemia
Gefitinib or Docetaxel
Non-Small Cell Lung Cancer
budesonode bid + terbutaline 'as needed'
Asthma
R-mini-CHOP
Large B-cell Lymphoma
Laroprovstat/Rosuvastatin 1
Hypercholesterolaemia
Double Blind Esomeprazole
Gastroesophageal Reflux Disease (GERD)
insulin lispro
Type 2 Diabetes Mellitus
Glycopyrronium/Formoterol Fumarate
Chronic Obstructive Pulmonary Disease COPD
Metformin immediate release (IR)
Type 2 Diabetes
Saxagliptin plus metformin IR
Type 2 Diabetes Mellitus
Symbicort TBH - Turbuhaler
Asthma
Olive oil
Hypertriglyceridemia
Eribulin
Breast Cancer
Goserelin acetate
Advanced Breast Cancer
Budesonide/albuterol metered-dose inhaler
Asthma, Exercise-Induced
glipizide
Type 2 Diabetes
Terbutaline Turbuhaler®
Asthma
Ribociclib
ER-Positive HER2-Negative Breast Cancer
Erlotinib
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
Formoterol Turbuhaler
Chronic Obstructive Pulmonary Disease
Durvalumab + Chemotherapy phase
Advanced or Recurrent Endometrial Cancer
Anastozole (Arimidex)
Breast Cancer
insulin detemir
Type 2 Diabetes Mellitus
Linaclotide
Irritable Bowel Syndrome With Constipation (IBS-C)
(Osimertinib cohort, single-arm, open-label separate cohort)
Carcinoma, Non-Small-Cell Lung
BFF MDI
Asthma
NXY-059
Intracerebral Hemorrhage
CRESTOR
Heart Failure
Pertuzumab
Breast Neoplasms
Seroquel Sustained Release (SR)
Schizophrenic Disorder
cisplatin + fluorouracil
Esophageal Squamous Cell Carcinoma
Ravulizumab
Thrombotic Microangiopathy
CAEL-101
AL Amyloidosis
AZD7442
COVID-19
Sebelipase alfa (SBC-102)
Lysosomal Acid Lipase Deficiency
Eculizumab
Atypical Hemolytic Uremic Syndrome
Surovatamig
B-cell Non-Hodgkin Lymphoma
Ticagrelor
Acute Coronary Syndrome
Volrustomig
Non-small Cell Lung Cancer
Eculizumab (Soliris®)
Shiga-like Toxin-producing Escherichia Coli
Andexanet
Bleeding
Epanova® (omega-3 carboxylic acids)
Diabetes Mellitus, Type 2
Casdatifan
Advanced Clear Cell Renal Cell Carcinoma
ALXN1850
Hypophosphatasia
ALXN2220
Transthyretin Amyloid Cardiomyopathy
sebelipase alfa
Cholesterol Ester Storage Disease (CESD)
C5 Inhibitor
Paroxysmal Nocturnal Hemoglobinuria
Danicopan
C3 Glomerulonephritis
asfotase alfa
Hypophosphatasia
pexelizumab in conjunction with CABG
Coronary Artery Disease
Tozorakimab Dose Regimen 1
Chronic Obstructive Pulmonary Disease
Elecoglipron
Type 2 Diabetes Mellitus
Sonesitatug vedotin
Gastric Cancer
Baxdrostat and dapagliflozin
Heart Failure
Aclidinium bromide/formoterol Fixed-Dose Combination
COPD
Foscarnet sodium
HIV Infections
Salbutamol pMDI
Asthma
Quetiapine fumarate
Schizophrenia
Durvalumab
Triple Negative Breast Cancer
Quetiapine fumarate (Seroquel)
Major Depressive Disorder
Anastrozole
Breast Cancer
Irinotecan
Neoplasms, Unknown Primary
Tamoxifen
Quality of Life
Omeprazole
Reflux Esophagitis
budesonide/formoterol Turbuhaler
Asthma
Esomeprazole
GERD
Rosuvastatin
Hypercholesterolemia
fluticasone/salmeterol (Advair Diskus)
Asthma
Hydrochlorothiazide
Type 2 Diabetes Mellitus
budesonide/formoterol (Symbicort)
Asthma
budesonide/formoterol
Asthma
Dapagliflozin
Diabetes Mellitus, Type 2
Pegylated G-CSF
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
Mometasone furoate or equivalent intranasal corticosteroid
Chronic Rhinosinusitis With Nasal Polyps
Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Open-label AZD9291
Stage IB-IIIA Non-small Cell Lung Carcinoma
Saxagliptin-Metformin XR
Polycystic Ovary Syndrome
R-miniCHOP + Acalabrutinib
Large B-cell Lymphoma
Quetiapine
Psychotic Disorders
DAPA/MET XR
Diabetes Prevention in Women After GDM Who Are at High-risk
Saracatinib
Ovarian Cancer
fluticasone/salmeterol (Advair)
Asthma
Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy
Asthma
Torvutatug samrotecan
Epithelial Ovarian Cancer
Benralizumab Arm C
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Quetiapine fumarate (Seroquel) SR
Affective Psychosis, Bipolar
Symbicort pMDI + budesonide HFA pMDI
Asthma
Luteinizing hormone-releasing hormone (LHRH) agonist
ER-Positive HER2-Negative Breast Cancer
Esomeprazole (Nexium)
Gastroesophageal Reflux Disease (GERD)
Metformin with titration
Type 2 Diabetes Mellitus
beta-II-agonist, inhale steroid
Asthma
Symbicort Turbuhaler (Budesonide/formoterol)
Chronic Obstructive Pulmonary Disease
Aromatase Inhibitor and Growth Hormone
Idiopathic Short Stature
Cisplatin/Etoposide
Non-Small Cell Lung Cancer
Leucovorin (in FOLFOX)
Colorectal Cancer
Alendronate sodium
Breast Cancer
fluticasone
Asthma
Open Label Run In Esomeprazole
Gastroesophageal Reflux Disease (GERD)
Extended release quetiapine (quetiapine XR)
Bipolar Disorder
Oxaliplatin (in FOLFOX)
Colorectal Cancer
Quetiapine Fumarate (SEROQUEL) Extended-Release (XR)
Schizophrenia
Budesonide HFA
Asthma
AZD 1222
COVID-19
Paclitaxel and Carboplatin
Breast Cancer
SSRI/Venlafaxine
Major Depressive Disorder
Cediranib Maleate
Advanced Malignant Solid Neoplasm
Pegylated Liposomal Doxorubicin Hydrochloride
Fallopian Tube Clear Cell Adenocarcinoma
Docetaxel Injectable Solution
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Bacillus Calmette-Guerin (BCG)
Non-muscle-invasive Bladder Cancer
Capivasertib plus Docetaxel
Metastatic Castration-resistant Prostate Cancer (mCRPC)
AZD6234
Obesity/Overweight
Niraparib plus Abiraterone acetate plus Prednisone
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Chemotherapy
Anticancer Treatment
Saruparib (AZD5305)
Ovarian Cancer
Ceftaroline fosamil
Infections
exenatide twice daily
Type 2 Diabetes Mellitus
Ciclesonide nasal
Rhinitis, Allergic, Perennial
Ticagrelor orodispersible tablets
ST Elevation Myocardial Infarction
Paroxetine
Generalized Anxiety Disorder
AZD2265
Metastatic Castration-resistant Prostate Cancer
Formoterol (OT)
Chronic Obstructive Pulmonary Disease
fostamatinib
Rheumatoid Arthritis
Fluorouracil implant
Early-stage Breast Cancer
bamlanivimab
Coronavirus
D961H
Reflux Esophagitis
Benralizumab Arm B
Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ZD9393 (Zoladex)
Breast Cancer
Olaparib
Breast Cancer Metastatic
ABT-335 and rosuvastatin calcium
Hypercholesterolemia
Formoterol Turbuhaler®
Chronic Obstructive Pulmonary Disease
Osimertinib (AZD9291) pemetrexed cisplatin or carboplatin
Non-small Cell Lung Cancer
Androgen blockade
Prostate Cancer
AC2993 (exenatide)
Diabetes Mellitus
ICI35,868 (propofol)
Gastrointestinal Endoscopy
MEDI6570
Coronary Heart Disease (CHD)
Tremelimumab monotherapy
Urothelial Bladder Cancer
Verinurad +Febuxostat
Hyperuricemia
B - Exenatide
Diabetes Mellitus, Type 2
ZD1839
Mesothelioma
AZD7594
Asthma
Ciclesonide/Formoterol Combination
Asthma
Ticagrelor Dose 1a + Dose 2a
Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease
CIN-107 dosing
Primary Aldosteronism
Calcium folinate
Gastroesophageal Adenocarcinoma
Nab-paclitaxel+carboplatin
Non-small Cell Lung Cancer NSCLC
Olaparib Continuous (28-Day cycle) BD
Metastatic Triple Negative Breast Cancer
PwO
Breast Cancer
SBC-103
Mucopolysaccharidosis IIIB
metreleptin
Overweight
AZD2287
Metastatic Prostate Cancer
[11C]AZ1419 3391
Advanced Solid Malignancies
Tomudex
Inoperable or Recurrent Rectal Cancer
AZD8965 low dose
Idiopathic Pulmonary Fibrosis (IPF)
Arimidex
Breast Cancer
Durvalumab Injection
Cancer
Trastuzumab Deruxtecan (T-DXd)
Gastroesophageal Adenocarcinoma
Omega-3 carboxylic acids
T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
AZD6489
RSV Respiratory Syncytial Virus
AZD3470
Lymphoma
AZD7009, no generic name available
Atrial Fibrillation
tralokinumab cohort 2
Idiopathic Pulmonary Fibrosis
AZD1940
Pain
Itacitinib
Lung Cancer
AZD9793 Intravenous (IV) monotherapy
Hepatocellular Carcinoma
Guadecitabine
Advanced Kidney Cancer
Anastrazole
Breast Cancer
LAS100977
Chronic Obstructive Pulmonary Disease (COPD)
ARM A Durvalumab/chemotherapy association
Ovarian Cancer
AZD0901
Gastric Cancer
AZD1446
Adult ADHD
AZD2927
Arrhythmia
cediranib and olaparib
Recurrent Platinum Resistant Ovarian Cancer
AZD0022
Advanced Solid Tumours
lesogaberan (AZD3355)
Gastroesophageal Reflux Disease
AZD0171
Locally Advanced or Metastatic Solid Tumours
AZD5363 when combined with weekly paclitaxel
Advanced or Metastatic Breast Cancer
ACH-0144471
Paroxysmal Nocturnal Hemoglobinuria
LHRH agonist
Prostate Cancer
Ciclesonide HFA
Rhinitis, Allergic, Seasonal
GC012F Injection
Refractory Systemic Lupus Erythematosus
AZD6738 and olaparib
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
Salmeterol
Chronic Obstructive Pulmonary Disease
AZD1775 and carboplatin (CBPT)
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
Rucaparib
Adenocarcinoma of the Oesophagus
ACH-0141625 (Sovaprevir)
Hepatitis C
Tarperprumig
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Osimertinib + Savolitinib
Non-Small Cell Lung Cancer
AZD1305
Atrial Fibrillation
Neoadjuvant Olaparib monotherapy group
Breast Cancer
Axicabtagene Ciloleucel
B-Cell Non-Hodgkin Lymphoma
TRIXEO AEROSPHERE
Copd
AZD4877
Bladder Cancer
AZD9056
Rheumatoid Arthritis
Casodex
Gynaecomastia
Lenvatinib
Hepatocellular Carcinoma
AZD4956
Solid Tumours
AZD5423
Chronic Obstructive Pulmonary Disease (COPD)
Atirmociclib
Advanced Breast Cancer
AZD9829
Hematological Malignancies
Metoprolol
Breast Cancer
AZD0530
Breast Cancer
Ticagrelor Tablets
Coronary Artery Disease
Formoterol Fumarate in the Pressair DPI, Low Dose
Asthma
Osimertinib First-Line
Non-Small Cell Lung Cancer
Bertilimumab
Pemphigoid, Bullous
AZD0305
Multiple Myeloma
AZD6738
Breast Neoplasm
ZD 1839
Esophageal Cancer
KU-0059436 (AZD2281)(PARP inhibitor)
Ovarian Neoplasm
Eptifibatide
Acute Coronary Syndrome
AZD5492
B-cell Malignancies
Vigil
Breast Cancer
Goserelin (Zoladex)
Breast Cancer
Selumetinib+Docetaxel
Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)
AZD5305
Ovarian Cancer
AZD5851
Hepatocellular Carcinoma
Febuxostat
Asymptomatic Hyperuricemia
AZD1386
Pain
AZD3632
Acute Lymphoblastic Leukaemia
exenatide once monthly suspension
Type 2 Diabetes
Tesaglitazar
Type 2 Diabetes
AZD7624
Chronic Obstructive Pulmonary Disease COPD
Aclidinium bromide and formoterol
Chronic Obstructive Pulmonary Disease (COPD)
Amivantamab
Non-Small Cell Lung Cancer (NSCLC)
AZD5315
Influenza A
Umbralisib
Chronic Lymphocytic Leukemia
AZD2423
Chronic Obstructive Pulmonary Disease
Ceralasertib
Advanced Solid Tumours
Zibotentan
Chronic Kidney Disease
Prednisone (or equivalent)
Chronic Lymphocytic Leukaemia
budesonide/formoterol, 2x 200/6 microgram. 4 times daily
Chronic Obstructive Pulmonary Disease
Selumetinib granule formulation
Neurofibromatosis Type 1
Durvalumab/Tremelimumab Combination Therapy
Pediatric Cancer
AZD3480
ADHD
AZD5004
Diabetes Mellitus, Type 2
Gefitinib, Irinotecan, Cycophosphamide, Doxorubicin, Etoposide, Cisplatin, Topotecan, Carboplatin, Melphalan, 13-cis retinoic acid
Neuroblastoma
AZD2265 (FPI-2265)
Metastatic Prostate Cancer
AZD5672
Rheumatoid Arthritis
NK3R antagonist - AZD4901
Menopausal Flushing
AZD3152
COVID-19, SARS-CoV-2
tralokinumab cohort 1
Idiopathic Pulmonary Fibrosis
Osimertinib & febuxostat
Non-Small Cell Lung Cancer
AZD2811
Small-Cell Lung Cancer
AZD9773
Severe Sepsis
Neoantigen DNA vaccine
Extensive-stage Small Cell Lung Cancer
AZD4117
Influenza A
AC2592
Congestive Heart Failure
AZD7325
Anxiety Disorders
AZD6765 iv
Major Depressive Disorder
AZD5462
Chronic Heart Failure
AZD1419
Asthma
ER tablet AZD3241
Parkinson's Disease
AZD8630
Asthma
AZD2389
Liver Fibrosis
AZD7648
Advanced Malignancies
Gefitinib, radiotherapy
Non-Metastatic Prostate Cancer
R-CHOP
Diffuse Large B Cell Lymphoma
AZD9773 (CytoFab)
Severe Sepsis
olaparib+durvalumab
Metastatic Pancreatic Cancer
AZD7268
Major Depressive Disorder
ACH-126,443
Hepatitis B, Chronic
Cotadutide
Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
Pentoxifylline
Non-Small Cell Lung Cancer
XELOX
Gastric Cancer
Loperamide
Metastatic HR+/HER2- Breast Cancer
ALXN2420
Acromegaly
ALXN1210
PNH
AZD3427
Pulmonary Hypertension (World Health Organization Group 2)
AZD1236
Chronic Obstructive Pulmonary Disease
AZD0292
Bronchiectasis With Pseudomonas Aeruginosa Colonization
AZD6765
Treatment Resistant Major Depressive Disorder
Bis-Choline Tetrathiomolybdate
Wilson Disease
Omega-3 carboxylic acid
Non-alcoholic Fatty Liver Disease (NAFLD
terbutaline
Exercise Induced Asthma
Gefitinib and capecitabine
Colorectal Cancer
Gefitinib, Cisplatin and Radiotherapy
Cancer of Head and Neck
AZD4547
FGFR Inhibition, Pharmacokinetics, Biomarkers
AZD4818
Chronic Obstructive Pulmonary Disease (COPD)
Anastrozole (ARIMIDEX™)
Gynecomastia
AB248
Advanced or Metastatic Non-small Cell Lung Cancer
AZD2066
Reflux Episodes
AZD5148
Clostridioides Difficile Infection
goserelin with dutasteride
Cancer
VKA INR 2-3
Persistent or Permanent Nonvalvular Atrial Fibrillation
ZD1839 in combination with docetaxel
Breast Neoplasms
Cisplatin-based neoadjuvant chemotherapy
Bladder Cancer
AZD2171
Metastatic Colorectal Cancer
AZD5863
Gastric Cancer
AZD8421
ER+ HER2- Advanced Breast Cancer
Tremelimumab Plus Durvalumab (MEDI4736)
Hepatocellular Carcinoma (HCC)
Etoposide with Carboplatin or Cisplatin
Extensive-Stage Small-Cell Lung Cancer
sibutramine
Overweight
AZD8233
Hyperlipidaemia
AZD6750
Melanoma
AS MDI
Asthma
Sodium Zirconium Cyclosilicate(ZS)
Hyperkalemia
Adavosertib
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
AZD8931
Neoplasms
ACH-3102
Hepatitis C, Chronic
AZD1656
Type 2 Diabetes Mellitus
gefitinib (IRESSA™, ZD1839)
Breast Cancer
AZD9567
Diabetes Mellitus, Type 2
AZD9668
Chronic Obstructive Pulmonary Disease
AZD6621
Prostate Cancer
AZD4144
Sepsis
AZD0516
Metastatic Prostate Cancer
SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)
AL Amyloidosis
AZD2516
Reflux
AZD8601
Heart Failure
Gefitinib retreatment
Carcinoma, Non-Small-Cell Lung
Cerdulatinib
Follicular Lymphoma (FL/Indolent NHL)
AZD4017
Raised Intraocular Pressure
AZD6094
Papillary Renal Cell Cancer
Acalabrutinib monotherapy
Mantle-cell Lymphoma
Iressa (ZD1839)
Nonresectable Adrenocortical Carcinoma
MEDI4736 in combination with nab-paclitaxel and gemcitabine
Metastatic Pancreatic Ductal Adenocarcinoma
AZD3199
COPD
AC2307
Obesity
AZD5213
Mild Cognitive Impairment
Dapagliflozin Tablet
Weight Loss
Administration of ceralasertib
Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
Consolidative Durvalumab
Non Small Cell Lung Cancer
MEDI9447
Triple Negative Breast Cancer
Lamivudine
HIV Infections
AZD4512
B-cell Non-Hodgkin Lymphoma
Durvalumab (Cohort 1-3)
Urothelial Carcinoma
Interferon beta-1a Nebuliser
Asthma
AZD4604
Asthma
Testosterone Enanthate
Castration-Resistant Prostate Carcinoma
AZD6244
Non Small Cell Lung Cancer
carboplatin AUC 2/paclitaxel
Esophageal Adenocarcinoma
CFI-400945
Breast Cancer
Ceralasertib OD + olaparib continuous BD (28-day cycle)
Metastatic Triple Negative Breast Cancer
Gelusil®
GERD
Etoposide, and cisplatin/carboplatin
Lung Cancer
vandetanib induction
Lung Cancer
AZD4017 and prednisolone
Iatrogenic Cushing's Disease
RDEA3170
Gout and Hyperuricemia
AZD9550
Overweight and Obesity
TEW-7197
Non-Small Cell Lung Cancer Metastatic
AZD2115
COPD
Adavosertib BD + olaparib BD (21-day cycle)
Metastatic Triple Negative Breast Cancer
Durvalumab, Tremelimumab and,FOLFOX
Colorectal Cancer Metastatic
Physicians Choice systemic chemotherapy
Breast Cancer
AZD5363
Non-small Cell Lung Cancer Metastatic
quetiapine (Seroquel) XR
Bipolar Depression
ALXN1840
Wilson Disease
Apelin
Cardiovascular Diseases
Standard-of-Care
HER2-positive Early Breast Cancer
AZD4547/anastrozole or letrozole
Breast Cancer
Monalizumab
Non-small Cell Lung Cancer
AZD0837
Nonvalvular Atrial Fibrillation
ALXN1920
Primary Membranous Nephropathy
Carboplatin or Cisplatin
Small Cell Lung Cancer
Bevespi
Chronic Obstructive Pulmonary Disease
AZD5213 + pregabalin
Diabetic Neuropathy, Painful; Diabetic Neuropathies
Paclitaxel/Carboplatin/Gefitinib
Non Small Cell Lung Cancer
AZD0486
Chronic Lymphocytic Leukaemia
AZD9150
Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck
AZD8205
Breast Cancer
Leucovorin LV
Endometrial Cancer
gefitinib and fulvestrant
Breast Cancer
AZD1163
Rheumatoid Arthritis
AZD2624
Schizophrenia
Formoterol/Budesonide
Obstructive Airway Disease
Olaparib Pill
High Grade Serous Carcinoma
Elvucitabine
Human Immunodeficiency Virus (HIV)-1 Infection
Amifostine
Chemotherapeutic Agent Toxicity
AZD4045
Relapsed or Refractory Multiple Myeloma
cis Platinum
Lung Cancer Stage II
Durvalumab + Tremelimumab + metronomic Vinorelbine
Advanced Solid Tumours
P-Sam
Adenoid Cystic Carcinoma
AZD7760
Staphylococcus Aureus
AZD4573
Advanced Haematological Malignancies
rAd26-S
COVID-19
Chemoradiotherapy arm
Oropharyngeal Squamous Cell Carcinoma
Zibotentan + dapagliflozin
Liver Cirrhosis
Dapagliflozin Tab
Chronic Kidney Diseases
AZD2014
Metastatic Breast Cancer
MEDI0382 low dose
Diabetes Mellitus, Type 2
ALXN2350
BAG3 Mutation Associated Dilated Cardiomyopathy
AZD0754
Metastatic Prostate Cancer
FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)
Metastatic Colorectal Cancer
CIN-107
Uncontrolled Hypertension
Cotadutide 100 micrograms
Type 2 Diabetes Mellitus
AZD 2014
Diffuse Large B-Cell Lymphoma
AZD8683
Chronic Obstructive Pulmonary Disease (COPD)
AZD5069
Asthma
AZD6793
Chronic Obstructive Pulmonary Disease (COPD)
AZD8359
Metastatic Prostate Cancer
Proventil
Asthma
AZD9574
Advanced Solid Malignancies
AZD9750
Prostate Cancer
ZD1839 (IRESSA™)
Head and Neck Cancer
Exenatide LAR
Type 2 Diabetes Mellitus
plevitrexed
Fallopian Tube Cancer
AZD1981
Asthma
Durvalumab and Tremelimumab
Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma
AZD0865
GERD Without Erosive Esophagitis
Atuliflapon
Asthma
[18F]AZD4694
Alzheimer's Disease
MEDI0382
Type 2 Diabetes
AZD7789
Carcinoma, Non-Small-Cell Lung
Benzbromarone
Gout and Asymptomatic Hyperuricemia
Fulvestrant injection
ER+ Breast Cancer
MEDI3506
Atopic Dermatitis
Sovaprevir
Hepatitis C, Chronic
CP-675,206
Malignant Melanoma
GC012F (AZD0120)
Relapsed/ Refractory Multiple Myeloma
AZD8848
Allergic Asthma
AZP-3601
Chronic Hypoparathyroidism
AZD7594 DPI
Asthma
Iressa
Locally Advanced Prostate Cancer
AZD9164
Chronic Obstructive Pulmonary Disease
Pramlintide and Metreleptin
Obesity
BMS-512148
Diabetes Mellitus, Type 2
ALXN2030
Antibody-Mediated Rejection
AZD2936
Non-Small-Cell Lung Carcinoma
AZD2281
Ovarian Neoplasms
SNDX-6352
Unresectable Intrahepatic Cholangiocarcinoma
CP-675,206 (Tremelimumab)
Colorectal Neoplasms
Anastrozole and goserelin
Breast Cancer
AZD3241
Multiple System Atrophy, MSA
AZD1775
Uterine Cancer
AZD2693
Nonalcoholic Steatohepatitis
AZD4901 (oral)
Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder
AZD4360
Gastric Cancer
ICI 182,780 (Faslodex)
Systemic Lupus Erythematosus
Acalabrutinib Oral Capsule + alloSCT
Chronic Lymphocytic Leukemia
Lymphodepleting chemotherapy
Refractory Aggressive B-cell Lymphomas
Aclidinium/formoterol
Chronic Obstructive Pulmonary Disease (COPD)
MEDI4736 monotherapy
Metastatic Pancreatic Ductal Adenocarcinoma
MEDI7352
Painful Osteoarthritis of the Knee
MEDI-545
Systemic Lupus Erythematosus
AZD0120
Lupus Erythematosus, Systemic
Epanova and Lovaza
Severe Hypertriglyceridemia
Mitiperstat (AZD4831)
Chronic Obstructive Pulmonary Disease (COPD)
AZD7798
Crohn's Disease
AZD5718
Coronary Artery Disease
exenatide (LY2148568)
Type 2 Diabetes Mellitus
Verinurad
Chronic Kidney Disease
Fluorouracil (5-FU)
Gastric Cancer
AZD8871
Chronic Obstructive Pulmonary Disease
AZD2327
Anxious Major Depressive Disorder
MEDI7183 low dose
Ulcerative Colitis
AZD9977
Heart Failure
CP-675,206 and leuprolide acetate and bicalutamide
Prostatic Neoplasms
Palacaparib
Ovarian Cancer
AZD 8529
Schizophrenia
Caprelsa (vandetanib)
Pancreatic Cancer
5-flourouracil
Squamous Cell Cancer
Fulvestrant + ZACTIMA
Metastatic Breast Cancer
AZD4635
Prostate Cancer
5-Fluorouracil (5-FU)
Gastroesophageal Adenocarcinoma
Danvatirsen
Non-Small Cell Lung Cancer
MEDI2070
Crohn's Disease
topotecan hydrochloride
Fallopian Tube Cancer
AZD3355
GERD
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
MEDI8897 | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
AZD1152 | Phase 3 | Acute Myeloid Leukemia | - | - |
Dapagliflozin propanediol (FORXIGA™/FARXIGA™1) | Phase 3 | AMI | - | - |
cyclophosphamide, bortezomib, and dexamethasone (CyBorD) regimen | Phase 3 | AL Amyloidosis | - | - |
NOLVADEX (tamoxifen) | Phase 3 | Breast Cancer | - | - |
AZD9291 | Phase 3 | Advanced Non Small Cell Lung Cancer | - | - |
Baxdrostat/dapagliflozin | Phase 3 | Chronic Kidney Disease and Hypertension | - | - |
Saruparib | Phase 3 | Prostate Cancer | - | - |
Sulphonylurea | Phase 3 | Type 2 Diabetes | - | - |
Datopotamab Deruxtecan | Phase 3 | Non-small Cell Lung Cancer | - | - |
Budesonide/formoterol pMDI + spacer | Phase 3 | Asthma | - | - |
Saxagliptin, Onglyza | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Theophylline | Phase 3 | Asthma | - | - |
Anastrazole (Arimidex) | Phase 3 | Breast Cancer | - | - |
Aclidinium bromide/formoterol Fixed-Dose Combination (FDC) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Gemcitabine + cisplatin + S-1 | Phase 3 | Biliary Tract Cancer | - | - |
Taxane | Phase 3 | Breast Cancer; HER2-positive; Metastatic | - | - |
Acetylsalicylic acid ASA | Phase 3 | Acute Coronary Syndrome | - | - |
Abiraterone Oral Tablet | Phase 3 | Metastatic Castration-resistant Prostate Cancer (mCRPC) | - | - |
Olanzapine, risperidone | Phase 3 | Schizophrenia | - | - |
Oleclumab | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Sodium Zirconium Cyclosilicate (ZS) | Phase 3 | Hyperkalemia | - | - |
Gefitinib | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Gemcitabine + S-1 | Phase 3 | Biliary Tract Cancer | - | - |
Tremelimumab | Phase 3 | Advanced Hepatocellular Carcinoma | - | - |
Aclidinium Bromide/Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Pramlintide acetate | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
Tozorakimab | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Medi-546 | Phase 3 | Systemic Lupus Erythematosus | - | - |
AZD9291 Dosing | Phase 3 | Lung Cancer | - | - |
Gemcitabine + cisplatin + albumin-bound paclitaxel | Phase 3 | Biliary Tract Cancer | - | - |
Tozorakimab Dose Regimen 2 | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Raloxifene | Phase 3 | Breast Cancer | - | - |
Ramucirumab+ paclitaxel | Phase 3 | Gastric Cancer | - | - |
Ciclesonide nasal spray | Phase 3 | Hay Fever | - | - |
Ropivacaine | Phase 3 | Anesthesia,Spinal | - | - |
AZD4831 | Phase 3 | Heart Failure With Preserved Ejection Fraction | - | - |
Seasonal influenza virus vaccine | Phase 3 | Asthma | - | - |
ARIMIDEX (anastrazole) | Phase 3 | Breast Cancer | - | - |
candsartan cilexetil | Phase 3 | Hypertension | - | - |
Gemcitabine/Cisplatin | Phase 3 | Biliary Tract Cancer | - | - |
Nexium | Phase 3 | Erosive Esophagitis | - | - |
Eplontersen | Phase 3 | Transthyretin Amyloid Cardiomyopathy | - | - |
omefas | Phase 3 | Severe Hypertriglyceridemia | - | - |
ZNS | Phase 3 | Migraine | - | - |
pexelizumab | Phase 3 | Cardio-pulmonary Bypass | - | - |
Benralizumab (Medi-563) | Phase 3 | Asthma | - | - |
SEROQUEL (quetiapine fumarate) Tablets | Phase 3 | Bipolar Disorder | - | - |
Lithium carbonate | Phase 3 | Acute Bipolar Depression | - | - |
Metformin XR | Phase 3 | Type 2 Diabetes | - | - |
Dato-DXd | Phase 3 | Breast Cancer | - | - |
SSRI/Clomipramine | Phase 3 | Obsessive Compulsive Disorder | - | - |
MEDI4736 + Tremelimumab | Phase 3 | Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN | - | - |
Escitalopram oxylate | Phase 3 | Generalized Anxiety Disorder | - | - |
Mepolizumab | Phase 3 | Eosinophilic Granulomatous Vasculitis | - | - |
Laroprovstat | Phase 3 | Hypercholesterolaemia | - | - |
HFA MDI | Phase 3 | Asthma | - | - |
Pulmicort (budesonide) Respules | Phase 3 | Asthma | - | - |
Symbicort | Phase 3 | COPD Patients | - | - |
Benralizumab | Phase 3 | Asthma | - | - |
exenatide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Durvalumab +Tremelimumab | Phase 3 | Non Small Cell Lung Carcinoma NSCLC | - | - |
Aclidinium bromide | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Saxagliptin, + insulin | Phase 3 | Type 2 Diabetes | - | - |
Exenatide (AC2993) | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Benralizumab + Mometasone Furoate | Phase 3 | Nasal Polyposis | - | - |
HFO-1234ze(E) | Phase 3 | Mucociliary Clearance | - | - |
Osimertinib | Phase 3 | Lung Cancer | - | - |
Tiotropium | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Terbutaline sulphate | Phase 3 | Asthma | - | - |
ALXN2060 | Phase 3 | Symptomatic Transthyretin Amyloid Cardiomyopathy | - | - |
Selumetinib | Phase 3 | Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV | - | - |
Metformin (blinded) | Phase 3 | Type 2 Diabetes | - | - |
Ciclesonide | Phase 3 | Perennial Allergic Rhinitis | - | - |
Baxdrostat | Phase 3 | Resistant Hypertension | - | - |
Aclidinium bromide/Formoterol Fumarate (AB/FF) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
TC-5214 | Phase 3 | Major Depressive Disorder | - | - |
Tezepelumab | Phase 3 | Moderate to Severe Asthma | - | - |
AZD9833 | Phase 3 | ER-Positive HER2-Negative Breast Cancer | - | - |
Benralizumab Arm A | Phase 3 | Moderate to Very Severe Chronic Obstructive Pulmonary Disease | - | - |
formoterol | Phase 3 | Asthma | - | - |
amoxicillin clavulanate | Phase 3 | Infections | - | - |
Saxagliptin | Phase 3 | Type 2 Diabetes | - | - |
Gefitinib (Iressa) | Phase 3 | Cancer | - | - |
MEDI4736 | Phase 3 | Squamous Cell Carcinoma of the Head and Neck | - | - |
Candesartan cilexetil | Phase 3 | Hypertension | - | - |
Citalopram | Phase 3 | Major Depressive Disorder | - | - |
Tamoxifen (Nolvadex) | Phase 3 | Breast Cancer | - | - |
BCG | Phase 3 | Non-Muscle- Invasive Bladder Cancer | - | - |
Durvalumab (MEDI4736) | Phase 3 | Non-muscle-invasive Bladder Cancer | - | - |
exenatide, long acting release | Phase 3 | Type 2 Diabetes Mellitus | - | - |
MEDI4736 (Durvalumab) + Tremelimumab | Phase 3 | Advanced Solid Malignancies | - | - |
Rosuvastatin (Crestor) | Phase 3 | Hypercholesterolemia | - | - |
BGF MDI | Phase 3 | Asthma | - | - |
Tezepelumab (APFS) | Phase 3 | Asthma | - | - |
BGF MDI HFO | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Datopotamab deruxtecan (Dato-DXd) | Phase 3 | Non-small Cell Lung Cancer (NSCLC) | - | - |
exenatide once weekly | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Gefitinib, raltitrexed | Phase 3 | Colorectal Cancer | - | - |
Zibotentan/Dapagliflozin | Phase 3 | Chronic Kidney Disease With High Proteinuria | - | - |
ABT-335 plus rosuvastatin | Phase 3 | Dyslipidemia | - | - |
Acetylsalicylic acid (ASA) | Phase 3 | Acute Ischaemic Stroke | - | - |
Quetiapine Fumarate (Seroquel™) drug, mood stabilizer (mood) | Phase 3 | Bipolar Disorder | - | - |
ATACAND | Phase 3 | Hypertension | - | - |
AC2993 | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Symbicort Turbuhaler | Phase 3 | Bronchial Asthma | - | - |
rosiglitazone | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Durvalumab plus chemotherapy | Phase 3 | Small Cell Lung Carcinoma Extensive Disease | - | - |
AZD5156 (Parent study Sentinel Safety Cohort) | Phase 3 | COVID-19, SARS-CoV-2 | - | - |
Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level | Phase 3 | Hyperkalaemia | - | - |
5-fluorouracil | Phase 3 | Colorectal Cancer | - | - |
Saxagliptin + Metformin | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Budesonide/formoterol (SYMBICORT) pMDI | Phase 3 | Asthma | - | - |
Nirsevimab | Phase 3 | Respiratory Syncytial Virus Infections | - | - |
Symbicort, used twice daily (b.i.d) and as needed (prn) | Phase 3 | Asthma | - | - |
Ranitidine | Phase 3 | Gastric Ulcer | - | - |
D9421-C | Phase 3 | Crohn's Disease | - | - |
Balcinrenone/dapagliflozin | Phase 3 | Renal Insufficiency, Chronic | - | - |
Pulmicort Turbuhaler | Phase 3 | Asthma | - | - |
Camizestrant | Phase 3 | Advanced Breast Cancer | - | - |
Cimetidine | Phase 3 | Stress Ulcer Prophylaxis | - | - |
Gemcitabine monotherapy | Phase 3 | Biliary Tract Cancer | - | - |
Puxitatug Samrotecan | Phase 3 | Endometrial Cancer | - | - |
FLOT chemotherapy | Phase 3 | Gastrointestinal Neoplasms | - | - |
5-fluorouracil (in FOLFOX) | Phase 3 | Colorectal Cancer | - | - |
Rilvegostomig | Phase 3 | Hepatocellular Carcinoma | - | - |
Daptomycin | Phase 3 | Skin Diseases | - | - |
Epanova | Phase 3 | Hypertriglyceridemia | - | - |
MEDI4736 (durvalumab) | Phase 3 | Non - Small Cell Lung Cancer NSCLC | - | - |
Intralipid | Phase 3 | Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy | - | - |
exenatide twice daily (BID) | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Thiazolidinedione (Pioglitazone) | Phase 3 | Type 2 Diabetes | - | - |
Roxadustat | Phase 3 | Anemia | - | - |
Cisplatin + Gemcitabine | Phase 3 | Unresectable Locally Advanced Urothelial Cancer | - | - |
ABT-143 | Phase 3 | Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia | - | - |
ZD4054 | Phase 3 | Prostate Cancer | - | - |
Capivasertib | Phase 3 | Triple Negative Breast Neoplasms | - | - |
corn oil control | Phase 3 | Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) | - | - |
Conventional Asthma Therapy | Phase 3 | Asthma | - | - |
Pemetrexed/Carboplatin | Phase 3 | Non-Small Cell Lung Cancer | - | - |
pravastatin | Phase 3 | Hyperlipoproteinemia Type III | - | - |
candesartan cilexetil (Atacand) | Phase 3 | Hypertension | - | - |
AZD1222 | Phase 3 | COVID-19 | - | - |
Durvalumab + SoC chemotherapy | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
ZD1839 (Gefitinib) | Phase 3 | Carcinoma | - | - |
faslodex | Phase 3 | Hormone Receptor Positive Breast Cancer | - | - |
Amitriptyline | Phase 3 | Major Depressive Disorder | - | - |
Single agent chemotherapy | Phase 3 | Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity | - | - |
Carboplatin+Paclitaxel | Phase 3 | Advanced Ovarian Cancer | - | - |
NKTR-118 | Phase 3 | Opioid-Induced Constipation (OIC) | - | - |
Zirconium Cyclosilicate | Phase 3 | Hyperkalemia | - | - |
Cediranib | Phase 3 | Metastatic Colorectal Cancer | - | - |
Olaparib tablets | Phase 3 | Epithelial Ovarian Cancer | - | - |
propranolol | Phase 3 | Migraine Without Aura | - | - |
Quetiapine SR | Phase 3 | Anxiety Disorders | - | - |
Metformin IR | Phase 3 | Type 2 Diabetes | - | - |
Domvanalimab | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Adjuvant durvalumab | Phase 3 | Non Small Cell Lung Cancer | - | - |
Lomustine Chemotherapy | Phase 3 | Recurrent Glioblastoma | - | - |
AZD2816 | Phase 3 | COVID-19 | - | - |
Rosuvastatin Dose 1 | Phase 3 | Dyslipidaemia | - | - |
Roflumilast | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Symbicort pMDI | Phase 3 | Asthma | - | - |
Acalabrutinib | Phase 3 | Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | - | - |
Seroquel SR | Phase 3 | Schizophrenia | - | - |
Anifrolumab | Phase 3 | Lupus Nephritis | - | - |
Savolitinib | Phase 3 | Carcinoma | - | - |
Exantide with Dapagliflozin | Phase 3 | Diabetes Mellitus | - | - |
Epoetin alfa | Phase 3 | Anemia | - | - |
Sodium Zirconium Cyclosilicate | Phase 3 | Hyperkalemia | - | - |
AZD5335 | Phase 3 | Epithelial Ovarian Cancer | - | - |
divalproex | Phase 3 | Bipolar I Disorder | - | - |
Laroprovstat/Rosuvastatin 2 | Phase 3 | Hypercholesterolaemia | - | - |
FG-4592 | Phase 3 | Anemia | - | - |
Esomeprazole (D961H) twice daily | Phase 3 | Refractory Reflux Esophagitis | - | - |
Chlorambucil | Phase 3 | Untreated Chronic Lymphocytic Leukemia | - | - |
Terbutaline Turbuhaler | Phase 3 | Asthma | - | - |
Rosuvastatin calcium | Phase 3 | Hypercholesteremia | - | - |
Tarlatamab | Phase 3 | Small-cell Lung Cancer | - | - |
Esomeprazole magnesium (Nexium) | Phase 3 | Zollinger-Ellison Syndrome | - | - |
tralokinumab | Phase 3 | Ulcerative Colitis | - | - |
Glyburide | Phase 3 | Diabetes | - | - |
Seloken ZOK/Toprol-XL | Phase 3 | Heart Failure, Congestive | - | - |
Lenbelintide | Phase 3 | Obesity or Overweight | - | - |
Quetiapine Fumarate Extended- Release | Phase 3 | Schizophrenia | - | - |
BDA MDI HFO | Phase 3 | Asthma | - | - |
Zolmitriptan | Phase 3 | Migraine | - | - |
biphasic insulin aspart | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Anastrozole (Arimidex) | Phase 3 | Breast Cancer | - | - |
MEDI3250 | Phase 3 | Healthy Japanese Children Age 7 Years Through 18 Years | - | - |
AZD0780 | Phase 3 | Heterozygous Familial Hypercholesterolaemia | - | - |
exenatide/insulin glargine | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Candesartan | Phase 3 | Congestive Heart Failure | - | - |
metoprolol succinate | Phase 3 | Hypertension | - | - |
carboplatin | Phase 3 | Ovarian Cancer | - | - |
Quetiapine XR | Phase 3 | Bipolar Disorder | - | - |
lithium | Phase 3 | Bipolar I Disorder | - | - |
Budesonide/formoterol pMDI | Phase 3 | Asthma | - | - |
Tamoxifen alone | Phase 3 | Early-stage Breast Cancer | - | - |
Exenatide once weekly suspension | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Esomeprazole IV | Phase 3 | Gastrointestinal Hemorrhage | - | - |
Ethyl-eicosapentaenoic acid (EPA) | Phase 3 | Schizophrenia | - | - |
Dapagliflozin 10 milligram (mg) | Phase 3 | COVID-19 | - | - |
Quetiapine Fumarate Sustained Release | Phase 3 | Major Depressive Disorder | - | - |
DS-8201a | Phase 3 | Colorectal Neoplasm | - | - |
Misoprostol | Phase 3 | Postpartum Hemorrhage | - | - |
budesonide (Pulmicort) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
MEDI4736 (Durvalumab)+Tremelimumab | Phase 3 | Non-Small-Cell Lung Carcinoma NSCLC | - | - |
budesonide and budesonide/formoterol | Phase 3 | Asthma | - | - |
Ipratropium bromide | Phase 3 | Asthma | - | - |
fluticasone/salmeterol | Phase 3 | Asthma | - | - |
Chemoimmunotherapy | Phase 3 | Chronic Lymphocytic Leukemia | - | - |
Androgen blockade + radiation therapy | Phase 3 | Prostate Cancer | - | - |
Ticagrelor mashed pills | Phase 3 | Acute Coronary Syndrome | - | - |
Fulvestrant | Phase 3 | Breast Neoplasm Female | - | - |
quetiapine fumarate or valproate | Phase 3 | Bipolar Disorder | - | - |
Administration of quetiapine XR | Phase 3 | Schizophrenia | - | - |
AZD0585 | Phase 3 | Hypertriglyceridemia | - | - |
Gefitinib or Docetaxel | Phase 3 | Non-Small Cell Lung Cancer | - | - |
budesonode bid + terbutaline 'as needed' | Phase 3 | Asthma | - | - |
R-mini-CHOP | Phase 3 | Large B-cell Lymphoma | - | - |
Laroprovstat/Rosuvastatin 1 | Phase 3 | Hypercholesterolaemia | - | - |
Double Blind Esomeprazole | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
insulin lispro | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Glycopyrronium/Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease COPD | - | - |
Metformin immediate release (IR) | Phase 3 | Type 2 Diabetes | - | - |
Saxagliptin plus metformin IR | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Symbicort TBH - Turbuhaler | Phase 3 | Asthma | - | - |
Olive oil | Phase 3 | Hypertriglyceridemia | - | - |
Eribulin | Phase 3 | Breast Cancer | - | - |
Goserelin acetate | Phase 3 | Advanced Breast Cancer | - | - |
Budesonide/albuterol metered-dose inhaler | Phase 3 | Asthma, Exercise-Induced | - | - |
glipizide | Phase 3 | Type 2 Diabetes | - | - |
Terbutaline Turbuhaler® | Phase 3 | Asthma | - | - |
Ribociclib | Phase 3 | ER-Positive HER2-Negative Breast Cancer | - | - |
Erlotinib | Phase 3 | Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer | - | - |
Formoterol Turbuhaler | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Durvalumab + Chemotherapy phase | Phase 3 | Advanced or Recurrent Endometrial Cancer | - | - |
Anastozole (Arimidex) | Phase 3 | Breast Cancer | - | - |
insulin detemir | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Linaclotide | Phase 3 | Irritable Bowel Syndrome With Constipation (IBS-C) | - | - |
(Osimertinib cohort, single-arm, open-label separate cohort) | Phase 3 | Carcinoma, Non-Small-Cell Lung | - | - |
BFF MDI | Phase 3 | Asthma | - | - |
NXY-059 | Phase 3 | Intracerebral Hemorrhage | - | - |
CRESTOR | Phase 3 | Heart Failure | - | - |
Pertuzumab | Phase 3 | Breast Neoplasms | - | - |
Seroquel Sustained Release (SR) | Phase 3 | Schizophrenic Disorder | - | - |
cisplatin + fluorouracil | Phase 3 | Esophageal Squamous Cell Carcinoma | - | - |
Ravulizumab | Phase 3 | Thrombotic Microangiopathy | - | - |
CAEL-101 | Phase 3 | AL Amyloidosis | - | - |
AZD7442 | Phase 3 | COVID-19 | - | - |
Sebelipase alfa (SBC-102) | Phase 3 | Lysosomal Acid Lipase Deficiency | - | - |
Eculizumab | Phase 3 | Atypical Hemolytic Uremic Syndrome | - | - |
Surovatamig | Phase 3 | B-cell Non-Hodgkin Lymphoma | - | - |
Ticagrelor | Phase 3 | Acute Coronary Syndrome | - | - |
Volrustomig | Phase 3 | Non-small Cell Lung Cancer | - | - |
Eculizumab (Soliris®) | Phase 3 | Shiga-like Toxin-producing Escherichia Coli | - | - |
Andexanet | Phase 3 | Bleeding | - | - |
Epanova® (omega-3 carboxylic acids) | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Casdatifan | Phase 3 | Advanced Clear Cell Renal Cell Carcinoma | - | - |
ALXN1850 | Phase 3 | Hypophosphatasia | - | - |
ALXN2220 | Phase 3 | Transthyretin Amyloid Cardiomyopathy | - | - |
sebelipase alfa | Phase 3 | Cholesterol Ester Storage Disease (CESD) | - | - |
C5 Inhibitor | Phase 3 | Paroxysmal Nocturnal Hemoglobinuria | - | - |
Danicopan | Phase 3 | C3 Glomerulonephritis | - | - |
asfotase alfa | Phase 3 | Hypophosphatasia | - | - |
pexelizumab in conjunction with CABG | Phase 3 | Coronary Artery Disease | - | - |
Tozorakimab Dose Regimen 1 | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Elecoglipron | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Sonesitatug vedotin | Phase 3 | Gastric Cancer | - | - |
Baxdrostat and dapagliflozin | Phase 3 | Heart Failure | - | - |
Aclidinium bromide/formoterol Fixed-Dose Combination | Phase 3 | COPD | - | - |
Foscarnet sodium | Phase 3 | HIV Infections | - | - |
Salbutamol pMDI | Phase 3 | Asthma | - | - |
Quetiapine fumarate | Phase 3 | Schizophrenia | - | - |
Durvalumab | Phase 3 | Triple Negative Breast Cancer | - | - |
Quetiapine fumarate (Seroquel) | Phase 3 | Major Depressive Disorder | - | - |
Anastrozole | Phase 3 | Breast Cancer | - | - |
Irinotecan | Phase 3 | Neoplasms, Unknown Primary | - | - |
Tamoxifen | Phase 3 | Quality of Life | - | - |
Omeprazole | Phase 3 | Reflux Esophagitis | - | - |
budesonide/formoterol Turbuhaler | Phase 3 | Asthma | - | - |
Esomeprazole | Phase 3 | GERD | - | - |
Rosuvastatin | Phase 3 | Hypercholesterolemia | - | - |
fluticasone/salmeterol (Advair Diskus) | Phase 3 | Asthma | - | - |
Hydrochlorothiazide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
budesonide/formoterol (Symbicort) | Phase 3 | Asthma | - | - |
budesonide/formoterol | Phase 3 | Asthma | - | - |
Dapagliflozin | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Pegylated G-CSF | Phase 3 | Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV | - | - |
Mometasone furoate or equivalent intranasal corticosteroid | Phase 3 | Chronic Rhinosinusitis With Nasal Polyps | - | - |
Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Open-label AZD9291 | Phase 3 | Stage IB-IIIA Non-small Cell Lung Carcinoma | - | - |
Saxagliptin-Metformin XR | Phase 3 | Polycystic Ovary Syndrome | - | - |
R-miniCHOP + Acalabrutinib | Phase 3 | Large B-cell Lymphoma | - | - |
Quetiapine | Phase 3 | Psychotic Disorders | - | - |
DAPA/MET XR | Phase 3 | Diabetes Prevention in Women After GDM Who Are at High-risk | - | - |
Saracatinib | Phase 3 | Ovarian Cancer | - | - |
fluticasone/salmeterol (Advair) | Phase 3 | Asthma | - | - |
Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy | Phase 3 | Asthma | - | - |
Torvutatug samrotecan | Phase 3 | Epithelial Ovarian Cancer | - | - |
Benralizumab Arm C | Phase 3 | Moderate to Very Severe Chronic Obstructive Pulmonary Disease | - | - |
Quetiapine fumarate (Seroquel) SR | Phase 3 | Affective Psychosis, Bipolar | - | - |
Symbicort pMDI + budesonide HFA pMDI | Phase 3 | Asthma | - | - |
Luteinizing hormone-releasing hormone (LHRH) agonist | Phase 3 | ER-Positive HER2-Negative Breast Cancer | - | - |
Esomeprazole (Nexium) | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
Metformin with titration | Phase 3 | Type 2 Diabetes Mellitus | - | - |
beta-II-agonist, inhale steroid | Phase 3 | Asthma | - | - |
Symbicort Turbuhaler (Budesonide/formoterol) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Aromatase Inhibitor and Growth Hormone | Phase 3 | Idiopathic Short Stature | - | - |
Cisplatin/Etoposide | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Leucovorin (in FOLFOX) | Phase 3 | Colorectal Cancer | - | - |
Alendronate sodium | Phase 3 | Breast Cancer | - | - |
fluticasone | Phase 3 | Asthma | - | - |
Open Label Run In Esomeprazole | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
Extended release quetiapine (quetiapine XR) | Phase 3 | Bipolar Disorder | - | - |
Oxaliplatin (in FOLFOX) | Phase 3 | Colorectal Cancer | - | - |
Quetiapine Fumarate (SEROQUEL) Extended-Release (XR) | Phase 3 | Schizophrenia | - | - |
Budesonide HFA | Phase 3 | Asthma | - | - |
AZD 1222 | Phase 3 | COVID-19 | - | - |
Paclitaxel and Carboplatin | Phase 3 | Breast Cancer | - | - |
SSRI/Venlafaxine | Phase 3 | Major Depressive Disorder | - | - |
Cediranib Maleate | Phase 3 | Advanced Malignant Solid Neoplasm | - | - |
Pegylated Liposomal Doxorubicin Hydrochloride | Phase 3 | Fallopian Tube Clear Cell Adenocarcinoma | - | - |
Docetaxel Injectable Solution | Phase 3 | Metastatic Castration-resistant Prostate Cancer (mCRPC) | - | - |
Bacillus Calmette-Guerin (BCG) | Phase 3 | Non-muscle-invasive Bladder Cancer | - | - |
Capivasertib plus Docetaxel | Phase 3 | Metastatic Castration-resistant Prostate Cancer (mCRPC) | - | - |
AZD6234 | Phase 3 | Obesity/Overweight | - | - |
Niraparib plus Abiraterone acetate plus Prednisone | Phase 3 | Metastatic Castration-resistant Prostate Cancer (mCRPC) | - | - |
Chemotherapy | Phase 3 | Anticancer Treatment | - | - |
Saruparib (AZD5305) | Phase 3 | Ovarian Cancer | - | - |
Ceftaroline fosamil | Phase 3 | Infections | - | - |
exenatide twice daily | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Ciclesonide nasal | Phase 3 | Rhinitis, Allergic, Perennial | - | - |
Ticagrelor orodispersible tablets | Phase 3 | ST Elevation Myocardial Infarction | - | - |
Paroxetine | Phase 3 | Generalized Anxiety Disorder | - | - |
AZD2265 | Phase 3 | Metastatic Castration-resistant Prostate Cancer | - | - |
Formoterol (OT) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
fostamatinib | Phase 3 | Rheumatoid Arthritis | - | - |
Fluorouracil implant | Phase 3 | Early-stage Breast Cancer | - | - |
bamlanivimab | Phase 3 | Coronavirus | - | - |
D961H | Phase 3 | Reflux Esophagitis | - | - |
Benralizumab Arm B | Phase 3 | Moderate to Very Severe Chronic Obstructive Pulmonary Disease | - | - |
ZD9393 (Zoladex) | Phase 3 | Breast Cancer | - | - |
Olaparib | Phase 3 | Breast Cancer Metastatic | - | - |
ABT-335 and rosuvastatin calcium | Phase 3 | Hypercholesterolemia | - | - |
Formoterol Turbuhaler® | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Osimertinib (AZD9291) pemetrexed cisplatin or carboplatin | Phase 3 | Non-small Cell Lung Cancer | - | - |
Androgen blockade | Phase 3 | Prostate Cancer | - | - |
AC2993 (exenatide) | Phase 2 | Diabetes Mellitus | - | - |
ICI35,868 (propofol) | Phase 2 | Gastrointestinal Endoscopy | - | - |
MEDI6570 | Phase 2 | Coronary Heart Disease (CHD) | - | - |
Tremelimumab monotherapy | Phase 2 | Urothelial Bladder Cancer | - | - |
Verinurad +Febuxostat | Phase 2 | Hyperuricemia | - | - |
B - Exenatide | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
ZD1839 | Phase 2 | Mesothelioma | - | - |
AZD7594 | Phase 2 | Asthma | - | - |
Ciclesonide/Formoterol Combination | Phase 2 | Asthma | - | - |
Ticagrelor Dose 1a + Dose 2a | Phase 2 | Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease | - | - |
CIN-107 dosing | Phase 2 | Primary Aldosteronism | - | - |
Calcium folinate | Phase 2 | Gastroesophageal Adenocarcinoma | - | - |
Nab-paclitaxel+carboplatin | Phase 2 | Non-small Cell Lung Cancer NSCLC | - | - |
Olaparib Continuous (28-Day cycle) BD | Phase 2 | Metastatic Triple Negative Breast Cancer | - | - |
PwO | Phase 2 | Breast Cancer | - | - |
SBC-103 | Phase 2 | Mucopolysaccharidosis IIIB | - | - |
metreleptin | Phase 2 | Overweight | - | - |
AZD2287 | Phase 2 | Metastatic Prostate Cancer | - | - |
[11C]AZ1419 3391 | Phase 2 | Advanced Solid Malignancies | - | - |
Tomudex | Phase 2 | Inoperable or Recurrent Rectal Cancer | - | - |
AZD8965 low dose | Phase 2 | Idiopathic Pulmonary Fibrosis (IPF) | - | - |
Arimidex | Phase 2 | Breast Cancer | - | - |
Durvalumab Injection | Phase 2 | Cancer | - | - |
Trastuzumab Deruxtecan (T-DXd) | Phase 2 | Gastroesophageal Adenocarcinoma | - | - |
Omega-3 carboxylic acids | Phase 2 | T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin) | - | - |
AZD6489 | Phase 2 | RSV Respiratory Syncytial Virus | - | - |
AZD3470 | Phase 2 | Lymphoma | - | - |
AZD7009, no generic name available | Phase 2 | Atrial Fibrillation | - | - |
tralokinumab cohort 2 | Phase 2 | Idiopathic Pulmonary Fibrosis | - | - |
AZD1940 | Phase 2 | Pain | - | - |
Itacitinib | Phase 2 | Lung Cancer | - | - |
AZD9793 Intravenous (IV) monotherapy | Phase 2 | Hepatocellular Carcinoma | - | - |
Guadecitabine | Phase 2 | Advanced Kidney Cancer | - | - |
Anastrazole | Phase 2 | Breast Cancer | - | - |
LAS100977 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
ARM A Durvalumab/chemotherapy association | Phase 2 | Ovarian Cancer | - | - |
AZD0901 | Phase 2 | Gastric Cancer | - | - |
AZD1446 | Phase 2 | Adult ADHD | - | - |
AZD2927 | Phase 2 | Arrhythmia | - | - |
cediranib and olaparib | Phase 2 | Recurrent Platinum Resistant Ovarian Cancer | - | - |
AZD0022 | Phase 2 | Advanced Solid Tumours | - | - |
lesogaberan (AZD3355) | Phase 2 | Gastroesophageal Reflux Disease | - | - |
AZD0171 | Phase 2 | Locally Advanced or Metastatic Solid Tumours | - | - |
AZD5363 when combined with weekly paclitaxel | Phase 2 | Advanced or Metastatic Breast Cancer | - | - |
ACH-0144471 | Phase 2 | Paroxysmal Nocturnal Hemoglobinuria | - | - |
LHRH agonist | Phase 2 | Prostate Cancer | - | - |
Ciclesonide HFA | Phase 2 | Rhinitis, Allergic, Seasonal | - | - |
GC012F Injection | Phase 2 | Refractory Systemic Lupus Erythematosus | - | - |
AZD6738 and olaparib | Phase 2 | Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma | - | - |
Salmeterol | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD1775 and carboplatin (CBPT) | Phase 2 | Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma | - | - |
Rucaparib | Phase 2 | Adenocarcinoma of the Oesophagus | - | - |
ACH-0141625 (Sovaprevir) | Phase 2 | Hepatitis C | - | - |
Tarperprumig | Phase 2 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | - | - |
Osimertinib + Savolitinib | Phase 2 | Non-Small Cell Lung Cancer | - | - |
AZD1305 | Phase 2 | Atrial Fibrillation | - | - |
Neoadjuvant Olaparib monotherapy group | Phase 2 | Breast Cancer | - | - |
Axicabtagene Ciloleucel | Phase 2 | B-Cell Non-Hodgkin Lymphoma | - | - |
TRIXEO AEROSPHERE | Phase 2 | Copd | - | - |
AZD4877 | Phase 2 | Bladder Cancer | - | - |
AZD9056 | Phase 2 | Rheumatoid Arthritis | - | - |
Casodex | Phase 2 | Gynaecomastia | - | - |
Lenvatinib | Phase 2 | Hepatocellular Carcinoma | - | - |
AZD4956 | Phase 2 | Solid Tumours | - | - |
AZD5423 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Atirmociclib | Phase 2 | Advanced Breast Cancer | - | - |
AZD9829 | Phase 2 | Hematological Malignancies | - | - |
Metoprolol | Phase 2 | Breast Cancer | - | - |
AZD0530 | Phase 2 | Breast Cancer | - | - |
Ticagrelor Tablets | Phase 2 | Coronary Artery Disease | - | - |
Formoterol Fumarate in the Pressair DPI, Low Dose | Phase 2 | Asthma | - | - |
Osimertinib First-Line | Phase 2 | Non-Small Cell Lung Cancer | - | - |
Bertilimumab | Phase 2 | Pemphigoid, Bullous | - | - |
AZD0305 | Phase 2 | Multiple Myeloma | - | - |
AZD6738 | Phase 2 | Breast Neoplasm | - | - |
ZD 1839 | Phase 2 | Esophageal Cancer | - | - |
KU-0059436 (AZD2281)(PARP inhibitor) | Phase 2 | Ovarian Neoplasm | - | - |
Eptifibatide | Phase 2 | Acute Coronary Syndrome | - | - |
AZD5492 | Phase 2 | B-cell Malignancies | - | - |
Vigil | Phase 2 | Breast Cancer | - | - |
Goserelin (Zoladex) | Phase 2 | Breast Cancer | - | - |
Selumetinib+Docetaxel | Phase 2 | Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) | - | - |
AZD5305 | Phase 2 | Ovarian Cancer | - | - |
AZD5851 | Phase 2 | Hepatocellular Carcinoma | - | - |
Febuxostat | Phase 2 | Asymptomatic Hyperuricemia | - | - |
AZD1386 | Phase 2 | Pain | - | - |
AZD3632 | Phase 2 | Acute Lymphoblastic Leukaemia | - | - |
exenatide once monthly suspension | Phase 2 | Type 2 Diabetes | - | - |
Tesaglitazar | Phase 2 | Type 2 Diabetes | - | - |
AZD7624 | Phase 2 | Chronic Obstructive Pulmonary Disease COPD | - | - |
Aclidinium bromide and formoterol | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Amivantamab | Phase 2 | Non-Small Cell Lung Cancer (NSCLC) | - | - |
AZD5315 | Phase 2 | Influenza A | - | - |
Umbralisib | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
AZD2423 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Ceralasertib | Phase 2 | Advanced Solid Tumours | - | - |
Zibotentan | Phase 2 | Chronic Kidney Disease | - | - |
Prednisone (or equivalent) | Phase 2 | Chronic Lymphocytic Leukaemia | - | - |
budesonide/formoterol, 2x 200/6 microgram. 4 times daily | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Selumetinib granule formulation | Phase 2 | Neurofibromatosis Type 1 | - | - |
Durvalumab/Tremelimumab Combination Therapy | Phase 2 | Pediatric Cancer | - | - |
AZD3480 | Phase 2 | ADHD | - | - |
AZD5004 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
Gefitinib, Irinotecan, Cycophosphamide, Doxorubicin, Etoposide, Cisplatin, Topotecan, Carboplatin, Melphalan, 13-cis retinoic acid | Phase 2 | Neuroblastoma | - | - |
AZD2265 (FPI-2265) | Phase 2 | Metastatic Prostate Cancer | - | - |
AZD5672 | Phase 2 | Rheumatoid Arthritis | - | - |
NK3R antagonist - AZD4901 | Phase 2 | Menopausal Flushing | - | - |
AZD3152 | Phase 2 | COVID-19, SARS-CoV-2 | - | - |
tralokinumab cohort 1 | Phase 2 | Idiopathic Pulmonary Fibrosis | - | - |
Osimertinib & febuxostat | Phase 2 | Non-Small Cell Lung Cancer | - | - |
AZD2811 | Phase 2 | Small-Cell Lung Cancer | - | - |
AZD9773 | Phase 2 | Severe Sepsis | - | - |
Neoantigen DNA vaccine | Phase 2 | Extensive-stage Small Cell Lung Cancer | - | - |
AZD4117 | Phase 2 | Influenza A | - | - |
AC2592 | Phase 2 | Congestive Heart Failure | - | - |
AZD7325 | Phase 2 | Anxiety Disorders | - | - |
AZD6765 iv | Phase 2 | Major Depressive Disorder | - | - |
AZD5462 | Phase 2 | Chronic Heart Failure | - | - |
AZD1419 | Phase 2 | Asthma | - | - |
ER tablet AZD3241 | Phase 2 | Parkinson's Disease | - | - |
AZD8630 | Phase 2 | Asthma | - | - |
AZD2389 | Phase 2 | Liver Fibrosis | - | - |
AZD7648 | Phase 2 | Advanced Malignancies | - | - |
Gefitinib, radiotherapy | Phase 2 | Non-Metastatic Prostate Cancer | - | - |
R-CHOP | Phase 2 | Diffuse Large B Cell Lymphoma | - | - |
AZD9773 (CytoFab) | Phase 2 | Severe Sepsis | - | - |
olaparib+durvalumab | Phase 2 | Metastatic Pancreatic Cancer | - | - |
AZD7268 | Phase 2 | Major Depressive Disorder | - | - |
ACH-126,443 | Phase 2 | Hepatitis B, Chronic | - | - |
Cotadutide | Phase 2 | Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis | - | - |
Pentoxifylline | Phase 2 | Non-Small Cell Lung Cancer | - | - |
XELOX | Phase 2 | Gastric Cancer | - | - |
Loperamide | Phase 2 | Metastatic HR+/HER2- Breast Cancer | - | - |
ALXN2420 | Phase 2 | Acromegaly | - | - |
ALXN1210 | Phase 2 | PNH | - | - |
AZD3427 | Phase 2 | Pulmonary Hypertension (World Health Organization Group 2) | - | - |
AZD1236 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD0292 | Phase 2 | Bronchiectasis With Pseudomonas Aeruginosa Colonization | - | - |
AZD6765 | Phase 2 | Treatment Resistant Major Depressive Disorder | - | - |
Bis-Choline Tetrathiomolybdate | Phase 2 | Wilson Disease | - | - |
Omega-3 carboxylic acid | Phase 2 | Non-alcoholic Fatty Liver Disease (NAFLD | - | - |
terbutaline | Phase 2 | Exercise Induced Asthma | - | - |
Gefitinib and capecitabine | Phase 2 | Colorectal Cancer | - | - |
Gefitinib, Cisplatin and Radiotherapy | Phase 2 | Cancer of Head and Neck | - | - |
AZD4547 | Phase 2 | FGFR Inhibition, Pharmacokinetics, Biomarkers | - | - |
AZD4818 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Anastrozole (ARIMIDEX™) | Phase 2 | Gynecomastia | - | - |
AB248 | Phase 2 | Advanced or Metastatic Non-small Cell Lung Cancer | - | - |
AZD2066 | Phase 2 | Reflux Episodes | - | - |
AZD5148 | Phase 2 | Clostridioides Difficile Infection | - | - |
goserelin with dutasteride | Phase 2 | Cancer | - | - |
VKA INR 2-3 | Phase 2 | Persistent or Permanent Nonvalvular Atrial Fibrillation | - | - |
ZD1839 in combination with docetaxel | Phase 2 | Breast Neoplasms | - | - |
Cisplatin-based neoadjuvant chemotherapy | Phase 2 | Bladder Cancer | - | - |
AZD2171 | Phase 2 | Metastatic Colorectal Cancer | - | - |
AZD5863 | Phase 2 | Gastric Cancer | - | - |
AZD8421 | Phase 2 | ER+ HER2- Advanced Breast Cancer | - | - |
Tremelimumab Plus Durvalumab (MEDI4736) | Phase 2 | Hepatocellular Carcinoma (HCC) | - | - |
Etoposide with Carboplatin or Cisplatin | Phase 2 | Extensive-Stage Small-Cell Lung Cancer | - | - |
sibutramine | Phase 2 | Overweight | - | - |
AZD8233 | Phase 2 | Hyperlipidaemia | - | - |
AZD6750 | Phase 2 | Melanoma | - | - |
AS MDI | Phase 2 | Asthma | - | - |
Sodium Zirconium Cyclosilicate(ZS) | Phase 2 | Hyperkalemia | - | - |
Adavosertib | Phase 2 | Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation | - | - |
AZD8931 | Phase 2 | Neoplasms | - | - |
ACH-3102 | Phase 2 | Hepatitis C, Chronic | - | - |
AZD1656 | Phase 2 | Type 2 Diabetes Mellitus | - | - |
gefitinib (IRESSA™, ZD1839) | Phase 2 | Breast Cancer | - | - |
AZD9567 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
AZD9668 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD6621 | Phase 2 | Prostate Cancer | - | - |
AZD4144 | Phase 2 | Sepsis | - | - |
AZD0516 | Phase 2 | Metastatic Prostate Cancer | - | - |
SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) | Phase 2 | AL Amyloidosis | - | - |
AZD2516 | Phase 2 | Reflux | - | - |
AZD8601 | Phase 2 | Heart Failure | - | - |
Gefitinib retreatment | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Cerdulatinib | Phase 2 | Follicular Lymphoma (FL/Indolent NHL) | - | - |
AZD4017 | Phase 2 | Raised Intraocular Pressure | - | - |
AZD6094 | Phase 2 | Papillary Renal Cell Cancer | - | - |
Acalabrutinib monotherapy | Phase 2 | Mantle-cell Lymphoma | - | - |
Iressa (ZD1839) | Phase 2 | Nonresectable Adrenocortical Carcinoma | - | - |
MEDI4736 in combination with nab-paclitaxel and gemcitabine | Phase 2 | Metastatic Pancreatic Ductal Adenocarcinoma | - | - |
AZD3199 | Phase 2 | COPD | - | - |
AC2307 | Phase 2 | Obesity | - | - |
AZD5213 | Phase 2 | Mild Cognitive Impairment | - | - |
Dapagliflozin Tablet | Phase 2 | Weight Loss | - | - |
Administration of ceralasertib | Phase 2 | Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer | - | - |
Consolidative Durvalumab | Phase 2 | Non Small Cell Lung Cancer | - | - |
MEDI9447 | Phase 2 | Triple Negative Breast Cancer | - | - |
Lamivudine | Phase 2 | HIV Infections | - | - |
AZD4512 | Phase 2 | B-cell Non-Hodgkin Lymphoma | - | - |
Durvalumab (Cohort 1-3) | Phase 2 | Urothelial Carcinoma | - | - |
Interferon beta-1a Nebuliser | Phase 2 | Asthma | - | - |
AZD4604 | Phase 2 | Asthma | - | - |
Testosterone Enanthate | Phase 2 | Castration-Resistant Prostate Carcinoma | - | - |
AZD6244 | Phase 2 | Non Small Cell Lung Cancer | - | - |
carboplatin AUC 2/paclitaxel | Phase 2 | Esophageal Adenocarcinoma | - | - |
CFI-400945 | Phase 2 | Breast Cancer | - | - |
Ceralasertib OD + olaparib continuous BD (28-day cycle) | Phase 2 | Metastatic Triple Negative Breast Cancer | - | - |
Gelusil® | Phase 2 | GERD | - | - |
Etoposide, and cisplatin/carboplatin | Phase 2 | Lung Cancer | - | - |
vandetanib induction | Phase 2 | Lung Cancer | - | - |
AZD4017 and prednisolone | Phase 2 | Iatrogenic Cushing's Disease | - | - |
RDEA3170 | Phase 2 | Gout and Hyperuricemia | - | - |
AZD9550 | Phase 2 | Overweight and Obesity | - | - |
TEW-7197 | Phase 2 | Non-Small Cell Lung Cancer Metastatic | - | - |
AZD2115 | Phase 2 | COPD | - | - |
Adavosertib BD + olaparib BD (21-day cycle) | Phase 2 | Metastatic Triple Negative Breast Cancer | - | - |
Durvalumab, Tremelimumab and,FOLFOX | Phase 2 | Colorectal Cancer Metastatic | - | - |
Physicians Choice systemic chemotherapy | Phase 2 | Breast Cancer | - | - |
AZD5363 | Phase 2 | Non-small Cell Lung Cancer Metastatic | - | - |
quetiapine (Seroquel) XR | Phase 2 | Bipolar Depression | - | - |
ALXN1840 | Phase 2 | Wilson Disease | - | - |
Apelin | Phase 2 | Cardiovascular Diseases | - | - |
Standard-of-Care | Phase 2 | HER2-positive Early Breast Cancer | - | - |
AZD4547/anastrozole or letrozole | Phase 2 | Breast Cancer | - | - |
Monalizumab | Phase 2 | Non-small Cell Lung Cancer | - | - |
AZD0837 | Phase 2 | Nonvalvular Atrial Fibrillation | - | - |
ALXN1920 | Phase 2 | Primary Membranous Nephropathy | - | - |
Carboplatin or Cisplatin | Phase 2 | Small Cell Lung Cancer | - | - |
Bevespi | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD5213 + pregabalin | Phase 2 | Diabetic Neuropathy, Painful; Diabetic Neuropathies | - | - |
Paclitaxel/Carboplatin/Gefitinib | Phase 2 | Non Small Cell Lung Cancer | - | - |
AZD0486 | Phase 2 | Chronic Lymphocytic Leukaemia | - | - |
AZD9150 | Phase 2 | Advanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and Neck | - | - |
AZD8205 | Phase 2 | Breast Cancer | - | - |
Leucovorin LV | Phase 2 | Endometrial Cancer | - | - |
gefitinib and fulvestrant | Phase 2 | Breast Cancer | - | - |
AZD1163 | Phase 2 | Rheumatoid Arthritis | - | - |
AZD2624 | Phase 2 | Schizophrenia | - | - |
Formoterol/Budesonide | Phase 2 | Obstructive Airway Disease | - | - |
Olaparib Pill | Phase 2 | High Grade Serous Carcinoma | - | - |
Elvucitabine | Phase 2 | Human Immunodeficiency Virus (HIV)-1 Infection | - | - |
Amifostine | Phase 2 | Chemotherapeutic Agent Toxicity | - | - |
AZD4045 | Phase 2 | Relapsed or Refractory Multiple Myeloma | - | - |
cis Platinum | Phase 2 | Lung Cancer Stage II | - | - |
Durvalumab + Tremelimumab + metronomic Vinorelbine | Phase 2 | Advanced Solid Tumours | - | - |
P-Sam | Phase 2 | Adenoid Cystic Carcinoma | - | - |
AZD7760 | Phase 2 | Staphylococcus Aureus | - | - |
AZD4573 | Phase 2 | Advanced Haematological Malignancies | - | - |
rAd26-S | Phase 2 | COVID-19 | - | - |
Chemoradiotherapy arm | Phase 2 | Oropharyngeal Squamous Cell Carcinoma | - | - |
Zibotentan + dapagliflozin | Phase 2 | Liver Cirrhosis | - | - |
Dapagliflozin Tab | Phase 2 | Chronic Kidney Diseases | - | - |
AZD2014 | Phase 2 | Metastatic Breast Cancer | - | - |
MEDI0382 low dose | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
ALXN2350 | Phase 2 | BAG3 Mutation Associated Dilated Cardiomyopathy | - | - |
AZD0754 | Phase 2 | Metastatic Prostate Cancer | - | - |
FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan) | Phase 2 | Metastatic Colorectal Cancer | - | - |
CIN-107 | Phase 2 | Uncontrolled Hypertension | - | - |
Cotadutide 100 micrograms | Phase 2 | Type 2 Diabetes Mellitus | - | - |
AZD 2014 | Phase 2 | Diffuse Large B-Cell Lymphoma | - | - |
AZD8683 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD5069 | Phase 2 | Asthma | - | - |
AZD6793 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD8359 | Phase 2 | Metastatic Prostate Cancer | - | - |
Proventil | Phase 2 | Asthma | - | - |
AZD9574 | Phase 2 | Advanced Solid Malignancies | - | - |
AZD9750 | Phase 2 | Prostate Cancer | - | - |
ZD1839 (IRESSA™) | Phase 2 | Head and Neck Cancer | - | - |
Exenatide LAR | Phase 2 | Type 2 Diabetes Mellitus | - | - |
plevitrexed | Phase 2 | Fallopian Tube Cancer | - | - |
AZD1981 | Phase 2 | Asthma | - | - |
Durvalumab and Tremelimumab | Phase 2 | Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma | - | - |
AZD0865 | Phase 2 | GERD Without Erosive Esophagitis | - | - |
Atuliflapon | Phase 2 | Asthma | - | - |
[18F]AZD4694 | Phase 2 | Alzheimer's Disease | - | - |
MEDI0382 | Phase 2 | Type 2 Diabetes | - | - |
AZD7789 | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
Benzbromarone | Phase 2 | Gout and Asymptomatic Hyperuricemia | - | - |
Fulvestrant injection | Phase 2 | ER+ Breast Cancer | - | - |
MEDI3506 | Phase 2 | Atopic Dermatitis | - | - |
Sovaprevir | Phase 2 | Hepatitis C, Chronic | - | - |
CP-675,206 | Phase 2 | Malignant Melanoma | - | - |
GC012F (AZD0120) | Phase 2 | Relapsed/ Refractory Multiple Myeloma | - | - |
AZD8848 | Phase 2 | Allergic Asthma | - | - |
AZP-3601 | Phase 2 | Chronic Hypoparathyroidism | - | - |
AZD7594 DPI | Phase 2 | Asthma | - | - |
Iressa | Phase 2 | Locally Advanced Prostate Cancer | - | - |
AZD9164 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
Pramlintide and Metreleptin | Phase 2 | Obesity | - | - |
BMS-512148 | Phase 2 | Diabetes Mellitus, Type 2 | - | - |
ALXN2030 | Phase 2 | Antibody-Mediated Rejection | - | - |
AZD2936 | Phase 2 | Non-Small-Cell Lung Carcinoma | - | - |
AZD2281 | Phase 2 | Ovarian Neoplasms | - | - |
SNDX-6352 | Phase 2 | Unresectable Intrahepatic Cholangiocarcinoma | - | - |
CP-675,206 (Tremelimumab) | Phase 2 | Colorectal Neoplasms | - | - |
Anastrozole and goserelin | Phase 2 | Breast Cancer | - | - |
AZD3241 | Phase 2 | Multiple System Atrophy, MSA | - | - |
AZD1775 | Phase 2 | Uterine Cancer | - | - |
AZD2693 | Phase 2 | Nonalcoholic Steatohepatitis | - | - |
AZD4901 (oral) | Phase 2 | Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder | - | - |
AZD4360 | Phase 2 | Gastric Cancer | - | - |
ICI 182,780 (Faslodex) | Phase 2 | Systemic Lupus Erythematosus | - | - |
Acalabrutinib Oral Capsule + alloSCT | Phase 2 | Chronic Lymphocytic Leukemia | - | - |
Lymphodepleting chemotherapy | Phase 2 | Refractory Aggressive B-cell Lymphomas | - | - |
Aclidinium/formoterol | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
MEDI4736 monotherapy | Phase 2 | Metastatic Pancreatic Ductal Adenocarcinoma | - | - |
MEDI7352 | Phase 2 | Painful Osteoarthritis of the Knee | - | - |
MEDI-545 | Phase 2 | Systemic Lupus Erythematosus | - | - |
AZD0120 | Phase 2 | Lupus Erythematosus, Systemic | - | - |
Epanova and Lovaza | Phase 2 | Severe Hypertriglyceridemia | - | - |
Mitiperstat (AZD4831) | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
AZD7798 | Phase 2 | Crohn's Disease | - | - |
AZD5718 | Phase 2 | Coronary Artery Disease | - | - |
exenatide (LY2148568) | Phase 2 | Type 2 Diabetes Mellitus | - | - |
Verinurad | Phase 2 | Chronic Kidney Disease | - | - |
Fluorouracil (5-FU) | Phase 2 | Gastric Cancer | - | - |
AZD8871 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD2327 | Phase 2 | Anxious Major Depressive Disorder | - | - |
MEDI7183 low dose | Phase 2 | Ulcerative Colitis | - | - |
AZD9977 | Phase 2 | Heart Failure | - | - |
CP-675,206 and leuprolide acetate and bicalutamide | Phase 2 | Prostatic Neoplasms | - | - |
Palacaparib | Phase 2 | Ovarian Cancer | - | - |
AZD 8529 | Phase 2 | Schizophrenia | - | - |
Caprelsa (vandetanib) | Phase 2 | Pancreatic Cancer | - | - |
5-flourouracil | Phase 2 | Squamous Cell Cancer | - | - |
Fulvestrant + ZACTIMA | Phase 2 | Metastatic Breast Cancer | - | - |
AZD4635 | Phase 2 | Prostate Cancer | - | - |
5-Fluorouracil (5-FU) | Phase 2 | Gastroesophageal Adenocarcinoma | - | - |
Danvatirsen | Phase 2 | Non-Small Cell Lung Cancer | - | - |
MEDI2070 | Phase 2 | Crohn's Disease | - | - |
topotecan hydrochloride | Phase 2 | Fallopian Tube Cancer | - | - |
AZD3355 | Phase 2 | GERD | - | - |
transthyretin-mediated amyloid cardiomyopathy
2 drugs in this indication
breast cancer
2 drugs in this indication
eosinophilic esophagitis
2 drugs in this indication
Diabetes Mellitus, Type 2
2 drugs in this indication
transthyretin-mediated amyloidosis cardiomyopathy
1 drug in this indication
Ovarian Cancer
1 drug in this indication
Beyond oncology
1 drug in this indication
Type 2 Diabetes Mellitus
1 drug in this indication
hypertension
1 drug in this indication
ATTR-CM
1 drug in this indication
first-line metastatic non-small cell lung cancer (mNSCLC)
1 drug in this indication
unresectable hepatocellular carcinoma
1 drug in this indication
HER2 positive breast cancer
1 drug in this indication
Obesity/Overweight
1 drug in this indication
rare muscle disease
1 drug in this indication
resectable gastric or gastroesophageal junction adenocarcinoma
1 drug in this indication
advanced breast cancer
1 drug in this indication
cancer
1 drug in this indication
First-line HR+/HER2- breast cancer
1 drug in this indication
First-line ER-positive breast cancer
1 drug in this indication
transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)
1 drug in this indication
heart disease
1 drug in this indication
Acute Myeloid Leukemia
1 drug in this indication
Diabetes Mellitus
1 drug in this indication
first-line breast cancer
1 drug in this indication
Coronary Heart Disease (CHD)
1 drug in this indication
solid tumours
1 drug in this indication
Urothelial Bladder Cancer
1 drug in this indication
Mesothelioma
1 drug in this indication
Anticancer Treatment
1 drug in this indication
COPD
1 drug in this indication
Infections
1 drug in this indication
muscle-invasive bladder cancer
1 drug in this indication
Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease
1 drug in this indication
cisplatin-ineligible muscle-invasive bladder cancer
1 drug in this indication
COPD and asthma
1 drug in this indication
Rhinitis, Allergic, Perennial
1 drug in this indication
Hepatitis C, Chronic
1 drug in this indication
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1 drug in this indication
high-risk early-stage breast cancer
1 drug in this indication
IgA nephropathy
1 drug in this indication
IgA nephropathy (IgAN)
1 drug in this indication
Adjuvant treatment of HER2-positive early breast cancer with residual invasive disease
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in AstraZeneca PLC's drug pipeline?→
CatalystAlert tracks 676 drug candidates in AstraZeneca PLC's (AZN) pipeline across Phase 3, Phase 2. Its lead program is Durvalumab (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is AstraZeneca PLC's next FDA catalyst?→
AstraZeneca PLC's (AZN) next tracked catalyst is a Phase 2 readout expected November 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track AZN biotech catalysts?→
Add AZN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow AstraZeneca PLC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.